Health Invest Partners Ab has filed its 13F form on July 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $221 Million distributed in 37 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $30.2M, Abb Vie Inc. with a value of $16.1M, Boston Scientific Corp with a value of $13.6M, Neurocrine Biosciences Inc with a value of $11.1M, and Merck & Co., Inc. with a value of $11M.

Examining the 13F form we can see an increase of $5.85M in the current position value, from $215M to 221M.

Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.

Portfolio value $221 Million
Healthcare: $221 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 37
  • Current Value $221 Million
  • Prior Value $215 Million
  • Filing
  • Period Q2 2025
  • Filing Date July 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 1 stocks
  • Additional Purchases 23 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 13 stocks
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.